TOPIC CENTER
818 Articles
Updated Oct 7, 2026
Articles
Latest reporting, analysis, interviews and insight from The Pharma Navigator editorial team.
-
Funding & InvestmentsBuilding a World-Class CDMO for Reliable Global Supply
4 min read • 2 years ago -
-
Manufacturing ServicesSamsung Biologics Secures Record USD 1.4 Billion Contract with European Client
4 min read • 2 years ago -
Regulatory & ComplianceModerna Secures U.S. Government Grant for Avian Influenza Vaccine Development
4 min read • 2 years ago -
Manufacturing ServicesBioCina and NovaCina Merge to Strengthen Australian CDMO Industry
4 min read • 2 years ago -
-
-
Funding & InvestmentsLotte Biologics Unveils Dual CDMO Strategy in U.S. and Korea
4 min read • 2 years ago -
Funding & InvestmentsDotBio and Bora Biologics Join Forces to Advance DB007
4 min read • 2 years ago -
M&ANovo Holdings Plans to Double Catalent’s Size Amid U.S. Manufacturing Focus
4 min read • 2 years ago -
Funding & Investments
BioDuro Expands Peptide Synthesis with New Shanghai Facility
4 min read • 2 years ago -
Join 50,000+ Pharma Professionals
Receive exclusive market analysis, biotech trends, regulatory intelligence, and executive briefings.
Advertisement here
As billionaires pour capital into age-reversal biotech, the ethical implications for public healthcare systems are.
